ライフサイエンスコーパス: adenosine 5'-triphosphate

1 s nucleotide (2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate).

2 esponse to uridine 5'-triphosphate than with adenosine 5'-triphosphate.

3 ine 5'-triphosphate and alpha,beta-methylene adenosine 5'-triphosphate.

4 ulation of the P2X7 purinergic receptor with adenosine 5'-triphosphate.

5 hat K501 in the KGAP sequence interacts with adenosine 5'-triphosphate.

6 escent analog 2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate.

7 y on oxidative phosphorylation to synthesize adenosine 5'-triphosphate.

8 f Buk2 complexed with (beta,gamma-methylene) adenosine 5'-triphosphate.

9 or antagonist 2',3'-O-(2,4,6-Trinitrophenyl) adenosine 5'-triphosphate (100 microM) indicating P2X re

10 e 5'-triphosphate and high concentrations of adenosine 5'-triphosphate (1000-5000 microM) caused a si

11 Superfusion of 2-methylthio-adenosine-5'-triphosphate (2-M-S-ATP) over quiescent myo

12 he corresponding ATP derivative 2-methylthio-adenosine-5'-triphosphate (2MeSATP) at 3.1 A resolution.

13 e selective P2X agonist alpha,beta-methylene-adenosine 5'-triphosphate (30 microM).

14 This analog, 8-[(4-azidophenacyl)thio]adenosine 5'-triphosphate (8-APAS-ATP) contains an aryl

15 vels of mitochondrial membrane potential and adenosine-5'-triphosphate, activation of caspase 3, and

16 d indices of lung tissue metabolic function (adenosine 5-triphosphate/adenosine 5-diphosphate ratio,

17 der of ATP > 2'- and 3'-O-(4-benzoyl-benzoyl)adenosine 5'-triphosphate alpha,beta-methyleneadenosine

18 ate, AMP-PNP (2 mM) or beta, gamma-methylene-adenosine 5'-triphosphate. AMP-PCP (2 mM).

19 alues for BzATP (2',3'-O-(4- benzoylbenzoyl) adenosine 5'-triphosphate), an antagonist of the P2Y(12)

20 gs were prevented by either coinfusion of an adenosine-5'-triphosphate analog or pretransfusion incub

21 Adenosine 5'-triphosphate and adenosine receptors have b

22 tation, which was mimicked by application of adenosine 5'-triphosphate and alpha,beta-methylene adeno

23 ion were potentiated by alpha,beta-methylene adenosine 5'-triphosphate and ARL-67156, an adenosine tr

24 d P2X(2/3) antagonist 2',3'-O-trinitrophenyl-adenosine 5'-triphosphate and by the nonselective P2 ant

25 The P2X7 receptor agonist benzoylbenzoyl-adenosine 5'-triphosphate and high concentrations of ade

26 sensitivity and Michaelis constants (Km) for adenosine 5'-triphosphate and substrate; however, the LA

27 Adenosine 5'-triphosphate and uridine 5'-triphosphate eq

28 In both cell types, adenosine 5'-triphosphate and uridine 5'-triphosphate in

29 o and in vivo to probe the roles of released adenosine-5'-triphosphate and adhesion in responses to (

30 nufacturers by monitoring the degradation of adenosine-5'-triphosphate and myo-inositol-1,2,3,4,5,6-h

31 rs the ability of red blood cells to release adenosine-5'-triphosphate and that impaired adenosine-5'

32 rate analog, Ap(CH2)pp (alpha,beta-methylene adenosine 5'-triphosphate), and cyclic AMP compete for t

33 nosine-5'-triphosphate release, supplemental adenosine-5'-triphosphate, and antibodies to red blood c

34 gues TNP-ATP [2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate] and TNP-ADP.

35 2'-Deoxy-3'-anthraniloyl adenosine-5-triphosphate (ANT-dATP) coordinated to Tb3+

36 2-propylthio-D-beta gamma-dichloromethylene adenosine 5'-triphosphate (AR-C67085), a P2Y12 receptor-

37 6-N,N-diethyl-beta-gamma-dibromomethylene-D-adenosine 5-triphosphate (ARL 67156), reduced the [Ca(2+

38 6-N,N-diethyl-beta,gamma-dibromomethylene-D-adenosine-5'-triphosphate (ARL67156) inhibition of nucle

39 6-N,N-diethyl-beta-gamma-dibromomethylene-D-adenosine-5'-triphosphate (ARL67156).

40 Extracellular adenosine 5' triphosphate (ATP) is a widespread cell-to-

41 tor fructose-6-phosphate (F6P) and substrate adenosine 5'-triphosphate (ATP) (in the presence and abs

42 Adenosine 5'-triphosphate (ATP) affects multiple intra-

43 We investigated the effects of adenosine 5'-triphosphate (ATP) alone and in combination

44 Adenosine conformations of adenosine 5'-triphosphate (ATP) and adenosine 5'-diphosp

45 Adenosine conformations of adenosine 5'-triphosphate (ATP) and adenosine 5'-monopho

46 he compounds are competitive with respect to adenosine 5'-triphosphate (ATP) and bind in the kinase A

47 D required Mg2+ or Mn2+ and preactivation by adenosine 5'-triphosphate (ATP) and was inhibited by kno

48 Adenosine 5'-triphosphate (ATP) and/or related nucleotid

49 the back hydrophobic pocket adjacent to the adenosine 5'-triphosphate (ATP) binding site.

50 Exogenous adenosine 5'-triphosphate (ATP) boosts these signaling p

51 o adenine, adenosine monophosphate, and then adenosine 5'-triphosphate (ATP) by 5'-methylthio-adenosi

52 mational change coupled to the hydrolysis of adenosine 5'-triphosphate (ATP) by a mechanism that rema

53 The adenosine 5'-triphosphate (ATP) competitive cyclin-depen

54 While, at low adenosine 5'-triphosphate (ATP) concentrations, motors d

55 ent conclusive evidence that the presence of adenosine 5'-triphosphate (ATP) facilitates non-equilibr

56 In contrast to UDP, activation by UTP or adenosine 5'-triphosphate (ATP) greatly increased Ca(m),

57 Adenosine 5'-triphosphate (ATP) has long been considered

58 Activation of a purinergic P2 receptor by adenosine 5'-triphosphate (ATP) has previously been show

59 Adenosine 5'-triphosphate (ATP) hydrolysis rate was quan

60 mbient conditions using chemical energy from adenosine 5'-triphosphate (ATP) hydrolysis.

61 The role of adenosine 5'-triphosphate (ATP) in the activation mechan

62 tection of inorganic phosphate released from adenosine 5'-triphosphate (ATP) in the glutamine synthet

63 only a slight effect, while the addition of adenosine 5'-triphosphate (ATP) increased the amplitude

64 level of delivery is largely temperature and adenosine 5'-triphosphate (ATP) independent, and the mem

65 Adenosine 5'-triphosphate (ATP) is a functional molecule

66 Extracellular adenosine 5'-triphosphate (ATP) is an essential signalin

67 We report that adenosine 5'-triphosphate (ATP) is the key neurotransmit

68 Adenosine 5'-triphosphate (ATP) may regulate neurotransm

69 This study examined whether adenosine 5'-triphosphate (ATP) modulated inhibitory gly

70 The effects of extracellular adenosine 5'-triphosphate (ATP) on pulmonary vagal affer

71 Adenosine 5'-triphosphate (ATP) per gram tissue decrease

72 Adenosine 5'-triphosphate (ATP) plays an essential role

73 Recent work has shown that adenosine 5'-triphosphate (ATP) plays an important role

74 We have investigated adenosine 5'-triphosphate (ATP) release from SaOS-2 oste

75 y diverse set of inhibitors that bind to the adenosine 5'-triphosphate (ATP) site of type II topoisom

76 Based on evidence that extracellular adenosine 5'-triphosphate (ATP) stimulates glucose relea

77 Mitochondrial adenosine 5'-triphosphate (ATP) synthase is a multiprote

78 activity of the electron transport chain and adenosine 5'-triphosphate (ATP) synthase with RNA interf

79 -energy phosphate content and limitations in adenosine 5'-triphosphate (ATP) synthesis rate occur dur

80 Addition of adenosine 5'-triphosphate (ATP) to a solution of the ani

81 of this study was to test the equivalency of adenosine 5'-triphosphate (ATP) to adenosine in their ab

82 Methanocarba-adenosine 5'-triphosphate (ATP) was fixed in either a No

83 f nucleobase/nucleotide (adenine, adenosine, adenosine 5'-triphosphate (ATP), adenosine 5'-monophosph

84 se preparation is competitively inhibited by adenosine 5'-triphosphate (ATP), an observation that ind

85 (dTMP-PCP), thymidine 5'-diphosphate (dTDP), adenosine 5'-triphosphate (ATP), and adenosine 5'-O-(3-t

86 diated by a purine neurotransmitter, such as adenosine 5'-triphosphate (ATP), binding to P2Y1 recepto

87 Adenosine, but not adenosine 5'-triphosphate (ATP), dose-dependently and re

88 glycolysis is an inefficient way to generate adenosine 5'-triphosphate (ATP), however, and the advant

89 nase (PPDK) catalyzes the interconversion of adenosine 5'-triphosphate (ATP), orthophosphate (P(i)),

90 AP23464, a potent adenosine 5'-triphosphate (ATP)-based inhibitor of Src a

91 Recognizing the association of adenosine 5'-triphosphate (ATP)-binding cassette (ABC) t

92 ance regulator (CFTR) is a membrane-spanning adenosine 5'-triphosphate (ATP)-binding cassette (ABC) t

93 a membrane protein complex, the heteromeric adenosine 5'-triphosphate (ATP)-binding cassette transpo

94 e found to maximize occupancy of the active, adenosine 5'-triphosphate (ATP)-bound mtHsp70 at the cha

95 esults in either the high-DNA affinity form (Adenosine 5'-triphosphate (ATP)-bound) or the more inact

96 AK), a primary enzyme in cell metabolism and adenosine 5'-triphosphate (ATP)-consuming processes, pla

97 surement of inorganic pyrophosphate (PPi) in adenosine 5'-triphosphate (ATP)-contaminated samples.

98 Adenosine 5'-triphosphate (ATP)-dependent chromatin remo

99 lar cargo transport, for which it hydrolyzes adenosine 5'-triphosphate (ATP).

100 bit the DnaK-mediated phosphate release from adenosine 5'-triphosphate (ATP).

101 nd-gated ion channels gated by extracellular adenosine 5'-triphosphate (ATP).

102 enhanced their activity after application of adenosine 5'-triphosphate (ATP, 1 mM) or alpha,beta-meth

103 Adenosine 5'-triphosphate (ATP, 30 microM) activated the

104 rker DNA and a low molecular weight analyte, adenosine 5'triphosphate (ATP), respectively.

105 th timing and force) and immediately measure adenosine 5(')-triphosphate (ATP) release and calcium mo

106 atalyzing process is that PKA can hydrolysis adenosine-5'-triphosphate (ATP) and ALP can hydrolysis p

107 in situ multiple fluorescence monitoring of adenosine-5'-triphosphate (ATP) and guanosine-5'-triphos

108 xocytosis of LBs, following stimulation with adenosine-5'-triphosphate (ATP) and phorbol 12-myristate

109 of phosphate containing metabolites such as adenosine-5'-triphosphate (ATP) and pyrophosphate (PPi).

110 Phosphate-containing metabolites such as adenosine-5'-triphosphate (ATP) and pyrophosphate play a

111 he insertion of aptamer sequences (e.g., the adenosine-5'-triphosphate (ATP) aptamer) or ion-binding

112 Here we utilize adenosine-5'-triphosphate (ATP) as a trigger for the con

113 The majority of biosensors for adenosine-5'-triphosphate (ATP) determination are based

114 Two selective chemosensors for adenosine-5'-triphosphate (ATP) determination featuring

115 The mechanically induced release of adenosine-5'-triphosphate (ATP) from osteoblastic cells

116 Extracellular Adenosine-5'-triphosphate (ATP) is an important multi-fu

117 We have shown that red blood cell (RBC) adenosine-5'-triphosphate (ATP) is better maintained and

118 Adenosine-5'-triphosphate (ATP) is generally regarded as

119 Extracellular Adenosine-5'-Triphosphate (ATP) is known to accumulate i

120 ytes can be termed as energy inefficient for adenosine-5'-triphosphate (ATP) production but energy ef

121 leading to reductions in lactate production, adenosine-5'-triphosphate (ATP) production, and reduced

122 stimulation induces the release of cellular adenosine-5'-triphosphate (ATP) that regulates T-cell ac

123 were found to selectively adsorb adenine and adenosine-5'-triphosphate (ATP), as compared to other nu

124 that associates with the MTase and catalyses Adenosine-5'-triphosphate (ATP)-dependent DNA translocat

125 P2X receptors are trimeric adenosine-5'-triphosphate (ATP)-gated cation channels in

126 substrate complexes allowed the detection of adenosine-5'-triphosphate (ATP, detection limit 10 muM).

127 Extracellular triphosphate nucleotides (adenosine 5'-triphosphate [ATP], uridine 5'-triphosphate

128 n addition to previously published assays of adenosine 5'-triphosphate binding and hydrolysis, measur

129 ABCC6, a member of the adenosine 5'-triphosphate-binding cassette family of gen

130 osine kinase domain of EGFR that bind to its adenosine-5' triphosphate-binding site.

131 nd the acceptor (2'(or 3')-O-(trinitrophenyl)adenosine 5'-triphosphate) binds reversibly to the activ

132 quencher for boron dipyrromethene-conjugated adenosine 5'-triphosphate (BODIPY-ATP) that is highly fl

133 the P2X(7) receptor agonist, (benzoylbenzoyl)adenosine 5' triphosphate (BzATP) or the alpha(1D)-AR ag

134 h the P2X7 receptor agonist, (benzoylbenzoyl)adenosine 5' triphosphate (BzATP), cholinergic agonist c

135 riphosphate) and 2',3'-O-(4-benzoyl-benzoyl) adenosine 5'-triphosphate (BzATP), but not by adenosine.

136 elective agonist, 2'-3'-O-(4-benzoylbenzoyl)-adenosine 5'-triphosphate (BzATP: 100 microM), triggers

137 receptor agonist 2'3'-O-(4-benzoyl-benzoyl)-adenosine 5'-triphosphate (BzATP; 10 microM) caused a ra

138 y addition of 2'- and 3'-O-(4-benzoylbenzoyl)adenosine 5'-triphosphate (BzATP; 30 microm) resulted in

139 of ATP or 2'- (or-3'-) O-(4-benzoylbenzoyl) adenosine 5'-triphosphate (BzBzATP) activated an inward

140 oquinolin-7,9-dione (1) was identified as an adenosine 5'-triphosphate competitive inhibitor of lck b

141 % flow, no changes in function were seen and adenosine 5'-triphosphate concentrations decreased durin

142 Adenosine 5'-triphosphate contributes to mechanosensory

143 with controls reflecting higher than normal adenosine 5'-triphosphate degradation in the malignant h

144 Uptake was adenosine 5'-triphosphate-dependent and linear over a 12

145 mark them for destruction by a multisubunit, adenosine 5'-triphosphate-dependent protease called the

146 The 26S proteasome is a large intracellular adenosine 5'-triphosphate-dependent protease that identi

147 (CTE) of simian retrovirus was identified as adenosine 5'-triphosphate-dependent RNA helicase A.

148 We also discuss evidence suggesting that adenosine-5'-triphosphate-dependent chromatin-remodeling

149 alpha,beta-Methylene adenosine 5'-triphosphate did not cause an increase in e

150 Using an adenosine 5'-triphosphate disodium salt (ATP) binding ap

151 n, phospholamban (PLN) is an inhibitor of an adenosine-5'-triphosphate-driven calcium pump, the Ca2+-

152 We show that an adenosine-5'-triphosphate-driven group II chaperonin, wh

153 iphosphate), and 2',3'-O-(4-benzoyl-benzoyl) adenosine 5'-triphosphate each induced cAMP accumulation

154 s were observed in a subpopulation of cells; adenosine 5'-triphosphate failed to elevate Cai in some

155 In addition, 2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate fluorescence titration of BVR

156 of the adenylation of 4-chlorobenzoate with adenosine 5'-triphosphate followed by acyl transfer from

157 pends in part on the release of antiadhesive adenosine-5'-triphosphate from red blood cells, and stor

158 ctive site for phosphate (P(i)) generated by adenosine 5'-triphosphate hydrolysis.

159 e in P-loop-containing enzymes that catalyze adenosine 5'-triphosphate hydrolysis.

160 The hydrolysis of adenosine 5'-triphosphate in solutions containing magnes

161 ion of P2X(7) receptors with (benzoylbenzoyl)adenosine 5'-triphosphate increased [Ca(2+)](i), peroxid

162 al preparation was used to elucidate whether adenosine 5'-triphosphate is released from the mucosa in

163 ed intracellular levels of G6P, lactate, and adenosine-5'-triphosphate, leading to improved functiona

164 Adenosine-5'-triphosphate levels and red cell recovery w

165 se reaction mixture generated from magnesium adenosine 5-triphosphate (MgATP) and 4-CBA in the absenc

166 P2X7 receptor antagonist, periodate oxidized adenosine 5'-triphosphate (o-ATP), substantially inhibit

167 Adenosine 5'-triphosphate or ATP is the primary energy s

168 Carbachol, 3'-O-(4-benzoyl)benzoyl adenosine 5'-triphosphate (P2X(7) receptor agonist), AG1

169 Adenosine 5'-triphosphate plays a role in peripheral sen

170 ned and showed the inhibitor residing in the adenosine 5'-triphosphate pocket of the enzyme.

171 rescence enhancement, we discovered a robust adenosine 5'-triphosphate-powered dsRNA translocation ac

172 Calcium stimulates mitochondrial adenosine 5'-triphosphate production, but can also initi

173 ectum led to pressure-dependent increases in adenosine 5'-triphosphate release from colorectal epithe

174 ood cells, and storage-induced deficiency in adenosine-5'-triphosphate release from transfused red bl

175 on of fresh red blood cells treated with the adenosine-5'-triphosphate release inhibitors glibenclami

176 Inhibiting adenosine-5'-triphosphate release promoted the adhesion

177 adenosine-5'-triphosphate and that impaired adenosine-5'-triphosphate release was injurious in vivo,

178 Manipulation of adenosine-5'-triphosphate release, supplemental adenosin

179 transducer that, upon binding galactose and adenosine 5'-triphosphate, relieves Gal80p repression.

180 Adenosine, after ectoenzymatic breakdown of adenosine 5'-triphosphate, seems to be involved in the l

181 Finally, mitochondrial adenosine 5'-triphosphate-sensitive K+ channels open, an

182 A structurally novel series of adenosine 5'-triphosphate-sensitive potassium (K(ATP)) c

183 articularly affected by alpha,beta-methylene adenosine 5'-triphosphate, suggesting a correlation betw

184 ation with the first enzyme in this pathway, adenosine-5'-triphosphate sulfurylase, conferred signifi

185 The interplay between adenosine 5'-triphosphate supply and demand, dictated by

186 y released to drive proton translocation and adenosine 5'-triphosphate synthesis.

187 lysis rate of 2', 3'-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate (TNP-ATP) by F1-ATPase require

188 O-(2,4,6-trinitrophenylcyclo-hexadienylidene)adenosine 5'-triphosphate (TNP-ATP) to maltose-binding f

189 eotide analog 2',3'-O-(2,4,6-trinitrophenyl) adenosine 5'-triphosphate (TNP-ATP), which acts as a flu

190 eotide analog 2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate (TNP-ATP).

191 ith AF-353 or 2',3'-O-(2,4,6-Trinitrophenyl)-adenosine-5'-triphosphate (TNP-ATP), structurally distin

192 or antagonist 2',3'-O-(2,4,6-Trinitrophenyl) adenosine 5'-triphosphate, TNP-ATP (100 microM).

193 es the conversion of glucose 1-phosphate and adenosine 5'-triphosphate to ADP-glucose and pyrophospha

194 ted with beta2, cytidine 5'-diphosphate, and adenosine 5'-triphosphate to generate a NH(2)Y(730)(*) i

195 talyzes the transfer of gamma-phosphate from adenosine 5(')-triphosphate to the threonine residue of

196 ropic receptor agonist, alpha,beta-methylene adenosine 5'-triphosphate, to distinguish the ADP-induce

197 ogue TNP-ATP [2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate] to investigate the two ATP-bi

198 ATP(o) and 2'- and 3'-O-(4-benzoylbenzoyl)adenosine 5'-triphosphate triethylammonium salt (Bz-ATP)

199 of sarcoplasmic reticulum Ca-release-induced adenosine 5'-triphosphate turnover as a potential minima

200 Paradoxically, it inhibits adenosine 5'-triphosphate turnover in the absence of act

201 In HaCaT cells, adenosine 5'-triphosphate, uridine 5'-triphosphate, and

202 able ATP analog, ADPCP (beta,gamma-methylene adenosine 5'-triphosphate), was able to support apoptoso

203 MantATP [2'(3')-O-(-N-methylanthraniloyl)-adenosine 5'-triphosphate] was employed as a fluorescenc